PROLOR Biotech, Inc. today announced positive results from a preclinical toxicology study designed to assess the safety and tolerability of PROLOR's proprietary long-acting reversible-pegylation technology.
URL: http://www.news-medical.net/news/20121017/Positive-results-from-PROLORs-Rpeg-preclinical-toxicology-study.aspx
No comments:
Post a Comment